Pharmacotherapy of Opioid Use Disorder: Treatment that Works

The Opioid Epidemic continues to evolve across the country. Synthetic opioids (fentanyl) have been the main cause of rising overdose deaths. The approach to treatment of Opioid Use Disorder (OUD) is multidisciplinary. Evidence-based pharmacologic treatments have been available for many years but access to appropriate care is limited. In this presentation the pharmacology of the FDA approved Medications for OUD will be reviewed along with the unique challenges, regulations, monitoring parameters, and access for each. Common barriers faced by patients seeking care and clinicians providing care will be reviewed including the significant effect of stigma.

Educational Objectives

After completion of this course, the participant will be able to:

  • Understand terminology used in medication treatment for Opioid Use Disorder (OUD)
  • Recognize the role of medications in a comprehensive team approach to treating OUD
  • Understand the basic pharmacology of FDA approved medications for OUD: methadone, buprenorphine, and naltrexone

3.0 CE’s Offered:

  • CHES-(Certified Health Education Specialist)
  • DMH-Addiction Therapist
  • DMH-Licensed Administrator
  • DMH-Mental Health Therapist
  • DMH-Intellectual and Developmental Disabilities Therapist
  • MAAP-Mississippi Association of Addiction Professionals
  • NBCC-National Board for Certified Counselors
  • SW-(Social Work)

Presenter

Samuel K. Parish, MD, FASAM

Location

Virtual

Date

Aug. 26, 2021

Time

8:30 am - 11:30 am

Presenter

Samuel K. Parish, MD, FASAM

Location

Virtual